uniQure
QURE
#5575
Rank
S$1.73 B
Marketcap
S$24.75
Share price
-5.09%
Change (1 day)
-32.19%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2026 (TTM): -S$0.31 Billion

According to uniQure's latest financial reports the company's current earnings are S$20.16 Million. In 2025 the company made an earning of -S$0.25 Billion, an increase over its 2024 earnings that were of -S$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.31 Billion20.63%
2025 -S$0.25 Billion-18.47%
2024 -S$0.31 Billion-22.65%
2023 -S$0.4 Billion139.01%
2022 -S$0.17 Billion-138.54%
2021 S$0.42 B-335.29%
2020 -S$0.19 Billion13.88%
2019 -S$0.17 Billion49.51%
2018 -S$0.11 Billion4.55%
2017 -S$0.11 Billion12.65%
2016 -S$90.94 Million-9.59%
2015 -S$0.11 Billion66.95%
2014 -S$60.25 Million30.8%
2013 -S$46.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$14.24 B-4,826.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$10.03 B-3,430.95%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-S$0.15 Billion-52.82%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-S$0.26 Billion-14.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$56.28 M-118.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-S$0.89 Billion 192.82%๐Ÿ‡บ๐Ÿ‡ธ USA